| INTRODUC TI ON
Dilated cardiomyopathy (DCM), the most common type of cardiomyopathy worldwide, is characterized by ventricular enlargement and systolic dysfunction with normal left ventricular wall thickness. 1 Generally, DCM diagnosis is performed by two-dimensional echocardiography. 2 DCM leads to developmental heart failure, decreased left ventricular contractile function, arrhythmias, conduction system abnormalities, thromboembolism, and sudden or heart failurerelated death. 3 Moreover, DCM is the third most frequent cause of heart failure and the most common condition requiring heart transplantation. 4 This disease also leads to an increased risk of morbidity and mortality. DCM is a general and mostly irreversible form of heart muscle disease, with an estimated prevalence of up to 1:2500;
its predicted incidence is 19 in 100 000 in China 5 and 1 in 400 in the United States. 1 In addition, DCM occurs more frequently in men than in women (2.5:1), and the distribution of DCM seems to have a population bias, occurring more frequently in African Americans than in Caucasians (2.5:1).
6,7
The infection-immune theory has long been hypothesized to explain the pathogenesis of etiologically unrecognized DCM. 8 Recent evidences had suggested that immune mediators trigger the onset and progression of DCM. 9, 10 Myocarditis or myocardial fibrosis due to the infiltration of inflammatory cells is the second most common cardiac complication of systemic lupus erythematosus (SLE). 11 Inflammation could either resolve or continue and result in cardiac remodeling, ventricular dilation with normal or reduced left ventricular wall thickness, and systolic dysfunction, which in turn results in DCM. 8 It has been reported that DCM is one of the most severe complications involving organs in SLE 12 and is also one of the cardiac manifestations of neonatal lupus (cardiac-NL) syndrome. 13 Furthermore, single nucleotide polymorphisms (SNPs), such as MCP-1 -2518 A/G (rs1024611), 14, 15 TNF-α -308G/A (rs1800629), 16, 17 CTLA-4+49 A/G (rs231775), 18, 19 and IL-6 -174 G/C (rs1800795), 20, 21 have also been found to be associated with the risk of DCM and SLE, supporting a genetic role for their shared susceptibility that predisposes individuals to these two immune-related diseases. Therefore, we assumed that both diseases (DCM and cardiac-NL) may share certain susceptibility polymorphic loci. To date, several susceptibility loci have been
shown to be associated with cardiac-NL by genome-wide association study (GWAS) 22 and large-scale investigation. 23 These include
and LINC00704 (rs1391511).
Cardiac-NL and DCM are immune-related diseases caused by inflammation; both result in the development of myocardial fibrosis. Additionally, considering the genetic overlap in immune-related diseases and the associations between these SNPs and cardiac-NL, we hypothesized that the rs2857595, rs3134942, rs2472299, rs2432143, rs2272381, rs1487982, and rs1391511 polymorphisms may constitute a genetic background that contributed to the development of DCM in the Chinese Han population. Therefore, in this study, we analyzed SNPs in these seven susceptibility loci for cardiac-NL to determine whether they conferred susceptibility to DCM in the Chinese Han population. 
| MATERIAL S AND ME THODS

| Participants
| DCM subgroups
To test the relationships between the SNPs and various clinical characteristics of DCM, cases were stratified based on 11 characteristics of patients with DCM ( 
| Genotyping of selected SNPs
The following SNPs were selected and genotyped: rs2857595, rs3134942, rs2472299, rs2432143, rs2272381, rs1487982, and rs1391511 ( Table 2 ). Candidate SNPs were selected based on previously demonstrated strong associations with cardiac-NL. We focused on functional SNPs with a minor allele frequency of more than 5% in the Chinese Han population.
Peripheral blood samples (2 mL) were collected from all participants. DNA from each patient and control was extracted from peripheral white blood cells using a commercial genomic DNA kit (Tiangen, Beijing, China) and stored at −80°C, in accordance with the manufacturer's instructions. DNA from all participants was genotyped using MassArray iPLEX system (San Diego, CA, USA) according to the manufacturer's protocol. We used MassArray Assay Design 4.0 software to design primers for multiplex polymerase chain reaction (PCR) and locus-specific single-base extension (Table S1 ). PCR was conducted in a 384-well plate, and the products were subjected to locus-specific single-base extension reactions. The final products were then desalted and transferred to a 384-element SpectroCHIP array (Agena, CA, USA). Genotyping was performed via matrixassisted laser desorption ionization time-of-flight mass spectrometry using MassArray Typer software.
| Association analysis of the genotyped SNPs
Seven SNPs were tested using chi-square (χ 2 ) tests in controls; any
SNPs that deviated from the Hardy-Weinberg equilibrium (HWE; P < .05 in the control groups) were removed from subsequent analysis (Table S2 ). The association between each SNP and susceptibility to DCM was evaluated by logistic regression analysis, conditioned using sex and age as covariates as the incidence of DCM is both sex-and age-related. For the testing of the genetic model (additive, dominant, and recessive models), genotype frequencies were analyzed using a logistic regression model adjusted for sex and age.
Data analysis was performed using PLINK 1.07. 25 The odds ratios (ORs) and 95% confidence intervals (95% CIs) were computed, and P values (corrected for multiple testing by permutation adjustment) of less than .05 (two-tailed) were considered to represent statistical significance.
| RE SULTS
| Characteristics of participants
A total of 821 participants, including 273 DCM cases and 548 controls, were recruited from the Chinese Han population. The clinical and demographic characteristics of patients with DCM are illustrated in Table 1 . There are no significant discrepancies between cases and controls in terms of age (P age = .40, t test). Also, the ratios of male to female are well matched (2.59:1 for the case group and 2.61:1 for the control group) and were consistent with previously reported data (2.5:1). 6, 7 The seven SNPs did not deviate from the HWE in healthy controls (all P values >.05), and the call rate was more than 95% (Table S2) . 
| NOTCH4 was significantly associated with DCM
The allele frequency distributions of the seven SNPs are shown in Table 3 . For the non-HLA class region, rs2472299, rs2432143, rs2272381, rs1487982, and rs1391511 did not show significant differences between cases and controls in terms of allele frequencies (all, P a > .05). For the HLA class region, the T allele frequency of rs3134942 in NOTCH4 was strongly associated with DCM (OR = 1.61, 95% CI: 1.15-2.27, P a = 6.57 × 10 −3 ). This indicated that the T allele of rs3134942 was associated with increased DCM risk by 61% compared with the G allele. However, for the other SNPs (rs2857595 in NCR3) in the HLA class region, no significant association was observed (P a > .05).
Further analysis was performed based on three genetic models (additive, dominant, and recessive models), and the results are summarized in Table 5 ).
| D ISCUSS I ON
In the present study, we investigated the genetic contributions of in Notch signaling components are implicated in coronary heart disease. 27 The present findings indicated that mutations in NOTCH4 may be associated with DCM risk. In situ hybridization experiments have shown that NOTCH4 transcripts are mostly restricted to endothelial cells both in embryonic and adult mammals, indicating a specific and significant role of NOTCH4 during vascular development. 28 Previous study showed that activated NOTCH4 inhibits angiogenesis, 29 and mice with mutations in genes encoding Notch system components presented major defects in vascular morphogenesis. 30 Moreover, Notch signaling is an evolutionarily conserved intercellular signaling pathway that regulates interactions between physically adjacent cells through the binding of Notch family receptors to their cognate ligands. These results suggested that NOTCH4
has a pivotal and important role in angiogenesis and vascular remodeling, which leads to myocardial ischemia and fibrosis, resulting in DCM. Here, our study showed that NOTCH4 (rs3134942) was For rs2472299 in CYP1A2, an association with DCM was observed using the dominant model. However, allelic testing revealed no significant association between rs2472299 and the development of DCM. This result may be attributable to the lack of association between DCM and CYP1A2. While, in the subgroup analysis, this SNP was found to be associated with smoking status in patients with DCM. Previous studies indicated that CYP1A2 is activated in smokers and plays an important role in phase I metabolism of compounds found in tobacco smoke, such as dioxins and polycyclic aromatic hydrocarbons. 31, 32 Most importantly, mutagens, such as aromatic amines found in tobacco smoke, were identified to increase the development of cardiovascular diseases in experimental animals. 33, 34 Thus, we assumed that polymorphisms in CYP1A2, particularly rs2472299, which is located in a promoter region, may potentially increase CYP1A2 activity and catalyze the production of more aromatic amines in patients who smoked, thereby resulting in susceptible to DCM. However, our study was limited at the genetic level, and functional studies are therefore required to interpret the biological significance of these loci and to determine their role in DCM.
In this study, a limitation was the relatively small sample size, which was attributable to our strict inclusion criteria and based on an assumption of 0.19‰ DCM prevalence in the Chinese population. 5 Here, only rs3134942 in NOTCH4 was identified as a susceptibilityassociated SNP for DCM. However, we suggest that further fine mapping of NOTCH4 gene using larger sample sizes should be performed to gain additional insights into the relationships between NOTCH4 and DCM susceptibility.
| CON CLUS IONS
In conclusion, we found that the rs3134942 in NOTCH4 may be involved in DCM risk in Han Chinese population. In addition, rs2472299 in CYP1A2 shows association with smoking status in patients with DCM but did not show any association with DCM susceptibility. Further analyses in larger and ethnically diverse populations were warranted to confirm these findings.
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